Loading...
Last update:  October 15, 2017
12:47 +1GMT

Allergenic Molecule  Act d 5Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE196990.53020100909, Bernardi ML
3.2.1 - Source Sensitized (IgE)2011ItalyIgE83510.30020110211, DAvino R
6.2 - General Population (Adults)2012SwedenIgE3710.00020120528, Patelis A
3.2.1 - Source Sensitized (IgE)2013ItalyIgE2841.76020130420, Palazzo P
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010Italy / Austria / Switzerland / NetherlandsIgE2372.53020101118, Bublin M
4.1.6 - Heterologous Source Sensitized (High IgE)2011ItalyIgE2144.20020110211, DAvino R
1.5 - Atopic Dermatitis, Diagnosed2014NetherlandsIgE2110.50020140331, Rockmann H
3.1.4 - Source Sensitized (SPT, IgE)2010Italy / Austria / Switzerland / NetherlandsIgE1980.51020101118, Bublin M
5.1.1 - Source Exposed (Symptoms)2012France / Italy / Netherlands / Switzerland / United KingdomIgE1819.00020121112, Le TM
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1400.00020130111, Ott H
1.3 - Rhinitis, Diagnosed2013BrazilIgE1011.90020130912, Lacerda Araujo LM
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2011ChinaIgE1000.00020111214, Zheng YW
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE992.02020110223, De Knop KJ
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE960.00020120528, Patelis A
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE761.30020131020, van Rhijn BD
4.1.6 - Heterologous Source Sensitized (High IgE)2011ItalyIgE600.00020110211, DAvino R
5.1.1 - Source Exposed (Symptoms)2012Bulgaria / Czech Republic / Lithuania / PolandIgE567.00020121112, Le TM
5.1.1 - Source Exposed (Symptoms)2012Greece / SpainIgE4518.00020121112, Le TM
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE372.70020090826, Ebo DG
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013ItalyIgE360.00020130420, Palazzo P
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013ItalySPT365.55020130420, Palazzo P
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010SwitzerlandIgE3020.00020100111, Bublin M
5.1.1 - Source Exposed (Symptoms)2012IcelandIgE294.00020121112, Le TM
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE220.00020091121, Ebo DG
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE200.00020091005, Ott H
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE205.00020091121, Ebo DG
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010ItalySPT11100.00020100909, Bernardi ML
Developed by
Panservice